Article ID Journal Published Year Pages File Type
5615420 Journal of Clinical Lipidology 2016 11 Pages PDF
Abstract
Gemcabene as add-on to stable statin therapy demonstrated additional dose-dependent and statistically significant reductions in LDL-C of >20% and CRP >40% compared to placebo. The results support gemcabene-continued development for patients requiring LDL-C lowering beyond that provided by background statin therapy.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Preview
Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patients
Authors
, , , , , ,